97 related articles for article (PubMed ID: 20870184)
1. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery.
de Luis DA; Sagrado MG; Pacheco D; Terroba MC; Martin T; Cuellar L; Ventosa M
Surg Obes Relat Dis; 2010; 6(5):516-20. PubMed ID: 20870184
[TBL] [Abstract][Full Text] [Related]
2. [C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese].
De Luis DA; González Sagrado M; Aller R; Izaola O; Conde R; Romero E
Endocrinol Nutr; 2010 Feb; 57(2):54-9. PubMed ID: 20189896
[TBL] [Abstract][Full Text] [Related]
3. Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion.
de Luis DA; Sagrado MG; Izaola O; Terroba MC; Cuellar L; Conde R; Martin T
Nutrition; 2008 Apr; 24(4):300-4. PubMed ID: 18280114
[TBL] [Abstract][Full Text] [Related]
4. G 1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion.
de Luis DA; Pacheco D; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; Cuellar L; Terroba MC; Martin T; Ventosa M
Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):197-201. PubMed ID: 20391958
[TBL] [Abstract][Full Text] [Related]
5. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss after a hypocaloric diet.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R
Metabolism; 2011 May; 60(5):730-4. PubMed ID: 20716455
[TBL] [Abstract][Full Text] [Related]
6. Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets.
Deluis DA; Sagrado MG; Aller R; Izaola O; Conde R
Metabolism; 2010 Sep; 59(9):1387-92. PubMed ID: 20102775
[TBL] [Abstract][Full Text] [Related]
7. Influence of lys656asn polymorphism of leptin receptor gene on surgical results of biliopancreatic diversion.
de Luis DA; Aller R; Sagrado MG; Izaola O; Terroba MC; Cuellar L; Conde R; Martin T
J Gastrointest Surg; 2010 May; 14(5):899-903. PubMed ID: 20213209
[TBL] [Abstract][Full Text] [Related]
8. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up.
de Luis DA; Pacheco D; Izaola O; Terroba MC; Cuellar L; Martin T
Ann Nutr Metab; 2008; 53(3-4):234-9. PubMed ID: 19088468
[TBL] [Abstract][Full Text] [Related]
9. The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women.
Monteleone P; Tortorella A; Martiadis V; Di Filippo C; Canestrelli B; Maj M
Psychoneuroendocrinology; 2008 May; 33(4):546-50. PubMed ID: 18295974
[TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile.
Palomar R; Fernández-Fresnedo G; Domínguez-Diez A; López-Deogracias M; Olmedo F; Martín de Francisco AL; Sanz de Castro S; Casado Martín F; Gómez-Fleitas M; Arias M; Fernández-Escalante C
Obes Surg; 2005; 15(6):794-8. PubMed ID: 15978149
[TBL] [Abstract][Full Text] [Related]
11. Effects of RS9939609 gene variant in FTO gene on weight loss and cardiovascular risk factors after biliopancreatic diversion surgery.
de Luis DA; Aller R; Conde R; Izaola O; Pacheco D; Sagrado MG; Primo D
J Gastrointest Surg; 2012 Jun; 16(6):1194-8. PubMed ID: 22311283
[TBL] [Abstract][Full Text] [Related]
12. C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; Romero E
Int J Obes (Lond); 2010 Mar; 34(3):511-5. PubMed ID: 20065978
[TBL] [Abstract][Full Text] [Related]
13. Bariatric Analysis and Reporting Outcome System (BAROS) following biliopancreatic diversion.
Moneghini D; Mittempergher F; Terraroli C; Di Fabio F
Ann Ital Chir; 2004; 75(4):417-20. PubMed ID: 15754690
[TBL] [Abstract][Full Text] [Related]
14. Relation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) with obesity and insulin resistance.
de Luis DA; González Sagrado M; Aller R; Izaola O; Conde R
Nutr Hosp; 2010; 25(6):993-8. PubMed ID: 21519771
[TBL] [Abstract][Full Text] [Related]
15. Bariatric surgery for high risk patients: first staged laparoscopic biliopancreatic diversion with duodenal switch for severe obesity.
Keidar A; Begleibter N; Chalaila A; Elazary R; Schweiger C; Rivkind A
Isr Med Assoc J; 2007 Aug; 9(8):616-7. PubMed ID: 17877071
[No Abstract] [Full Text] [Related]
16. Results of biliopancreatic diversion after five years.
Guedea ME; Arribas del Amo D; Solanas JA; Marco CA; Bernadó AJ; Rodrigo MA; Diago VA; Díez MM
Obes Surg; 2004; 14(6):766-72. PubMed ID: 15318979
[TBL] [Abstract][Full Text] [Related]
17. Effect of biliopancreatic diversion on hypertension in severely obese patients.
Adami GF; Papadia F; Carlini F; Murelli F; Scopinaro N
Hypertens Res; 2005 Feb; 28(2):119-23. PubMed ID: 16025738
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
[TBL] [Abstract][Full Text] [Related]
19. Effect of the rs10767664 Variant of the Brain-Derived Neurotrophic Factor Gene on Weight Change and Cardiovascular Risk Factors in Morbidly Obese Patients after Biliopancreatic Diversion Surgery.
de Luis DA; Izaola O; Primo D; Pacheco D
J Nutrigenet Nutrigenomics; 2016; 9(2-4):116-122. PubMed ID: 27544754
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients.
Silecchia G; Boru C; Pecchia A; Rizzello M; Casella G; Leonetti F; Basso N
Obes Surg; 2006 Sep; 16(9):1138-44. PubMed ID: 16989696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
